An Exploratory Study of Esketamine in Patients After Thoracoscopic Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 7, 2022

Primary Completion Date

February 20, 2023

Study Completion Date

February 28, 2023

Conditions
EsketamineThoracoscopic Surgery
Interventions
DRUG

Esketamine

Self-controlled intravenous analgesia pump was used for continuous injection, and it was prepared according to sufentanil 1.5ug/ml+ esketamine 0.75ug/ml+16mg ondansetron. After the operation, the analgesic pump was connected, and sufentanil 0.1ug/kg/h+ esketamine 0.05mg/kg/h was pumped continuously for 24 hours. The continuous infusion of analgesia pump is (kg body weight/15) ml/h. (e.g. 60kg, pump speed 4ml/h, total amount 96ml).

Trial Locations (2)

400010

Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing

The Second Affiliated Hospital, Chongqing Medical University, Chongqing

All Listed Sponsors
lead

The Second Affiliated Hospital of Chongqing Medical University

OTHER